Â¥
34.22
May 10
New Key Statistics Module, Z-Score and F-Score
SZSE:300294 Key Ratios
Market Cap ¥ M | 17,255.39 |
Enterprise Value ¥ M | 11,711.42 |
P/E(ttm) | 79.58 |
PE Ratio without NRI | 42.35 |
Forward PE Ratio | -- |
Price/Book | 2.31 |
Price/Sales | 7.53 |
Price/Free Cash Flow | 37.85 |
Price/Owner Earnings | 140.27 |
Payout Ratio % | 0.25 |
Revenue (TTM) ¥ M | 2,294.00 |
EPS (TTM) ¥ | 0.43 |
Beneish M-Score | -3.06 |
10-y EBITDA Growth Rate % | 9.70 |
5-y EBITDA Growth Rate % | -8.20 |
y-y EBITDA Growth Rate % | -46.90 |
EV-to-EBIT | 36.07 |
EV-to-EBITDA | 36.07 |
PEG | -- |
Shares Outstanding M | 504.25 |
Net Margin (%) | 9.55 |
Operating Margin % | 23.62 |
Pre-tax Margin (%) | 14.13 |
Quick Ratio | 12.87 |
Current Ratio | 14.08 |
ROA % (ttm) | 2.71 |
ROE % (ttm) | 2.95 |
ROIC % (ttm) | 16.16 |
Dividend Yield % | 0.88 |
Altman Z-Score | 20.10 |
SZSE:300294 Number of Guru Trades
SZSE:300294 Volume of Guru Trades
Gurus Latest Trades with SZSE:300294
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
SZSE:300294 is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
China Resources Boya Bio-pharmaceutical Group Co Ltd Insider Transactions
No Available Data